Article
Emerging roles of pulmonary macrophages in driving the development of severe asthma
1 Feb 2012
Abstract excerpt
Asthma is recognized as a heterogeneous disorder, although in most patients, the clinical manifestations are effectively managed with established combination therapies. However, 5-10% of asthmatics have severe asthma, which does not respond to treatment, and these patients account for >50% of asthma-related healthcare costs. New investigations into the pathogenesis of glucocorticoid resistance in severe asthma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
